Home     Mail     Links     Articles     Reports     Correspondence     An effective prevention for AIDS     Español  


An effective prevention for AIDS

This article was written in June 2000
and posted during the Internet Discussion
of the South African Presidential AIDS Advisory Panel

The official measures to prevent AIDS are based on the belief that AIDS is a sexually transmitted viral disease. Accordingly, official efforts, in both developed and underdeveloped countries, are directed to educating people about what is called homosexual and heterosexual "save sex", to providing "clean syringes" to IV drug users, to transfusing "HIV-negative blood", and to preventing "vertical transmission" ¾ mother to child ¾ by medicating "HIV-positive" pregnant women, their fetuses, and newborns with the toxic AZT drug, by promoting cesarean section for delivery and by stopping the healthy practice of breastfeeding. In Africa efforts also aim at promoting male genital mutilation (circumcision) ¾ see my post on "Circumcision and AIDS in Africa" (1-9).

Much effort, time, and money has also been spent, predictably without success, in trying to develop a vaccine against HIV/AIDS (10,11).

No public health benefits have been achieved after almost two decades of practicing the above measures (12-14). Moreover, since the official preventive measures do not point to the real cause of AIDS ¾ the inmunological stressor or oxidizing agents (15-20) ¾ the proponents of those measures in fact promote the very disease that they are supposed to prevent. In Western countries, for example, some people, following the official advice, use condoms for "save sex" but at the same time use immunodepressive inhalant nitrites ¾ poppers ¾ and similar aphrodisiacs and other destructive drugs during their sexual practices. Also, in the West, IV drug addicted individuals are provided with free "clean syringes" to inject themselves with heroine, cocaine, and other drugs known to be capable of destroying the immune system (17,19). These measures, in addition to being ineffective, promote drug addiction and drug trafficking.

For Africa, Asia, and the Caribbean, official measures promote such things as heterosexual safe sex with condoms and male circumcision, as well as the toxic drug AZT for everyone who reacts positively on "the tests for HIV" or for those who are supposed to be "HIV-positive." They also promote stopping breastfeeding (1-9,21). They pretend to combat with these interventions the worst consequence of poverty and social inequity ¾ AIDS (22,23). Therefore, in the underdeveloped world, the official measures to prevent AIDS are by themselves immunological stressors that contribute to the destruction of the immune system and to the genesis of AIDS.

As a consequence, the official measures to combat AIDS are in fact new risk factors for the syndrome created by the defenders of the HIV/AIDS hypothesis.

Prevention measures in accordance with the real causes of AIDS

As was explained in my post, "The tests for HIV are highly inaccurate", individuals who react positively on the so-called "tests for HIV" are at higher risk for AIDS because they are more intoxicated or oxidized, not because they are infected with a virus named HIV (24-26). In accordance with this, it is necessary to prevent AIDS in individuals who react positively on the "tests for HIV", as well as in the groups of people who develop AIDS more frequently, and in the population at large. Consistent measures can be taken to prevent AIDS in all of these groups. However, as was explained in my post about "The natural history of AIDS" the etiologic or causal factors for AIDS – immunological stressors – change from person to person, from risk group to risk group, from country to country, and from continent to continent (17-20); so that for each group and location there must be applied different specific interventions. In African countries and similar communities the reactivity on "the tests for HIV" is a consequence of an over-stimulation/activation of the immune system secondary to infections, parasites, malnutrition, multiple pregnancies, poor sanitary conditions, and lack of clean water (17-20).

The so-called "long-term survivors" or "non-progressors" are people who react positively on "the tests for HIV" but who do not take AZT or any other antiretroviral drug and who avoid as much as they can exposures to immunological stressors or oxidizing agents (27,28). These individuals teach us how to prevent the development of AIDS.

The following are the six main principles that may lead to the prevention of AIDS:

1. Cause and sources should be pointed out

There is a world of difference between preventing AIDS if the cause is HIV and preventing AIDS if the cause is immunological stressor or oxidizing agents. The two approaches are antagonistic.

The principles listed here aim to prevent AIDS as a toxic/nutritional degenerative condition and not as a sexually transmitted viral disease. In previous postings I provided a wealth of scientific arguments indicating that AIDS is a toxic-nutritional syndrome caused by the alarming worldwide increment of immunological stressor or oxidizing agents (17-20,22,23).

The true causes should be explained in detail to individuals and to the community so that they can participate and contribute in preventing, controlling and overcoming AIDS. People should know that they can be exposed to immunological stressors involuntarily through their conditions of life and voluntarily through their life styles (12-20). In this way, they can take appropriate actions to protect themselves.

2. Avoid as much as possible exposures to immunological stressor or oxidizing agents

When preventing AIDS, present and past exposure to immunological stressor agents should be investigated with meticulous care in both individual and community. See my posts on "The Natural History of AIDS" and "Co-factors cause ADIS" for a list of the principle immunological stressors in the groups at risk for AIDS in developed and underdeveloped countries.

Detailed explanation on how and why to avoid exposures to these agents should be explained to everyone (12-20).

It is absolutely necessary to convince people who react positively on "the tests for HIV"
that they are not infected with "the virus that causes AIDS." The feeling of being infected with the virus that supposedly causes AIDS is a strong mental stressor that degenerates the immune system of both individuals and the community (29-34). The HIV/AIDS hypothesis contributes by itself to generating immunosupression and AIDS. In order to prevent AIDS the "HIV/AIDS hysteria" must be stopped immediately.

As I explained in "The Natural History of AIDS", in Africa, Asia, the Caribbean and similar communities, malnutrition and other conditions due to poverty, also known as "tropical diseases", have substantial roles in degenerating the immune system and causing AIDS (12-20). As a consequence, in the underdeveloped world, malnutrition, tuberculosis, sexually transmitted diseases, malaria, trypanosomiasis, schystosomiasis, leishmaniasis, systemic mycosis, as well as other infections and parasites that destroy and bring the immune system into collapse, need to be controlled at once and for ever as a prerequisite to stopping the epidemic of AIDS. For the prevention of AIDS in these communities it is absolutely necessary to first reverse economic and social inequities.

3. To evaluate health status based on clinical and laboratory findings

It is necessary to remember that the reactivity on " the tests for HIV" – ELISA, Western blot, P 24 antigen, PCR or viral load – is caused by intoxication/oxidation rather than by being infected with HIV, as I explained in detail in "Tests for HIV are highly inaccurate" (24-26).

In any person who reacts positively to those tests or wants, for any reason, to prevent AIDS, that person’s health status must be evaluated carefully by clinical and laboratory techniques. In this regard, laboratory tests should be carried out to evaluate the physiologic status of all body systems and especially the immune system (35-37).

To check the status of the immune system several tests should be done. In addition to counting the CD4 T lymphocytes all the different T and B lymphocytes subsets should be counted. It is very important to evaluate the functioning status of all immunocompetent cells and phagocytes with tests such as lymphoblastotransformation, inhibition of migration, etc (36,38). It is necessary to know the levels all complement components, betha 2 microglobulin, as well as to check for protein electrophoresis, immunoelectrophoresis, quantitation of serum immunoglobulins (G, A, M, D, E), check for a variety of autoantibodies, circulating immune complexes, and to perform skin tests with various antigens (39-42).

Evaluation of the nutritional status is critical. Tests to determine the levels of macro and micronutrients should be run. Levels of B complex vitamins, vitamin A, C, E, selenium, iron, and zinc should be evaluated (43-46).

It is absolutely necessary to evaluate the level of intoxication or degree of oxidation of the immune system and of all other body systems (37,47). Considering that AIDS is a condition due to an excess on free radicals, especially oxidizing species, it is absolutely necessary to evaluate the oxidative status by means of the modern tests available to check for the biomarkers of oxidative stress (48-55).

The measures to be taken in order to prevent AIDS should be proportional to the level of intoxication of the individual or the community.

4. Detoxification of already intoxicated body systems including the immune system

There has been a flowering of natural non-toxic measures to detoxify individuals through the named complementary, holistic or alternative therapies (56,57).

The following are some of the measures that have been reported to have benefits in the detoxification process:

· Antioxidants: It is important to emphasize that the role of oxidizing agents in immunosuppresion and in the genesis of AIDS has been pointed out in great scientific detail (15,16,58-82). As a consequence, several antioxidant substances and compounds such as vitamin C, A, and E, gluthatione, cysteine, zinc, selenium, etc., have been used with success in the detoxifying process (83-95).

· Nutrition: The correction of any nutritional abnormality and disturbance must be achieved in order to prevent AIDS. Several diets and nutritional interventions have been used with success (96-103).

· Other alternative interventions include the following non-toxic approaches, techniques that have been reported to have substantial benefits in the detoxifying process: acupuncture, digitopuncture, Chinese traditional medicine, herbal medicine, Indian ayurvedic medicine, hyperthermia, oxygen therapy, massage therapy, homeopathy, naturopathic and colon therapy, music therapy, color therapy, gem therapy, aromatherapy, hypnosis therapy, light therapy, yoga, magnetic field therapy, orthomolecular medicine, cell therapy, and spiritual care (57,104-113).

5. Stimulate the weakened immune system and all other systems that might already be weakened

Several immunomodulators and immune system stimulants have been used with success (114,115).

These include several interferons, interleukines, and growth factors, (114), B-complex vitamins (116), and lithium (117,118). Herbs such as ginsengs, eleuthero, sarsaparilla, sassafras, ashwagandha, Chinese cucumber, curcumin, catharanthus, podophyllum, pacific yew, mistletoe, echinacea, Aloe vera, garlic, Uncaria tomentosa are some of the more often used (119-124).

Coping with mental stress is critical to both detoxification and stimulation of the weakened immune and other systems (29-34).

There are excellent publications that may be useful as guides toward an effective prevention of AIDS (57,83,102,119,123-125).

6. Participation of complementary practitioners and indigenous healers must be encouraged

Since the beginning, complementary practitioners and indigenous healers have been dealing with the treatment and prevention of AIDS from an alternative viewpoint. Investigation of these approaches should be mandatory.

Any country that is serious and consistent in its commitment to overcoming AIDS must permit and stimulate the participation of indigenous natural healers in research and clinical fields. Indigenous healers should be part of the teams treating and preventing AIDS.

Possible clinical trial

To determine whether the prevention of AIDS with non-toxic measures is or is not more effective than the official prevention methods it will be necessary to have two groups of HIV-positive non-symptomatic individuals from the different groups of people at risk for AIDS. Both groups need to have individuals from all ages from developed and underdeveloped countries. The first group of individuals should be treated with the official antiretroviral drugs and the second group should be provided with the non-toxic measures described in this article.

Both groups must be followed for several years with clinical and laboratory evaluations.


  1. Centers for Disease Control and Prevention. Administration of Zidovudine during late pregnancy and delivery to prevent perinatal HIV transmission – Thailand, 1996-1998. MMWR 1998; 47: 151-154.
  2. UNAIDS. HIV and infant feeding. A review of HIV transmission through breastfeeding. UNAIDS/WHO Joint United Nations Programme on HIV? AIDS (UNAIDS). Geneva: WHO, June 1998.
  3. Brody S. Lifetime Number of Sexual Partners, Frequency of Sexual Intercourse, Hygiene, Race and AIDS. In: Sex at Risk: Lifetime Number of Partners, Frequency of Intercourses and the Low AIDS Risk of Vaginal Intercourse. New Brunswick/London: Transaction Publishers 1997: 137-146.
  4. Cohen MS et al. The Global Prevention of HIV. In: Sande MA, Volberding P. The Medical Management of AIDS. 6th Edition. Philadelphia: WB Saunders Company. 1999: 499-512.
  5. Fang H et al. Future Directions in Combating AIDS. In: The Biology of AIDS. Boston: Jones & Bartlett Publishers. 4th Edition. 2000: 155-176.
  6. Mantell JE, DiVittis AT, Auervach MI. Applying Theory to HIV Prevention Interventions. In: AIDS Prevention and Mental Health: Evaluating HIV Prevention Interventions. New York: Plenum Press, 1997: 179-204.
  7. Ostrow DG. Practical Prevention Issues. In: Ostrow DG, Kalichman SC. Psychosocial and Public Health Impact of New HIV Therapies. New York: Kluwer Academic/Plenum Publishers, 1999: 151-170.
  8. Kovacs A, Scott GB. Advances in the Management and Care of HIV positive Newborns and Infants. In: Pizzo PA, Wilfert CM. Pediatric AIDS: the Challenge of HIV Infection in Infants, Children, and Adolescents. Baltimore: Williams and Wilkins, 1998: 567-592.
  9. Peterman TA, Cates W & Wasserbeit JN. Prevention of the Sexual Transmission of HIV. In: DeVita VT, Hellman S & Rosenberg SA. AIDS: Etiology, Diagnosis, Treatment, and Prevention. p.443-452. JB Lippincott Company, Philadelphia, 1992.
  10. Kahn JO. An AIDS Vaccine: Will We Have One Soon?. In: Sande MA, Volberding PA. The Medical Management of AIDS. Fourth Edition. p.703-714. WB Saunders Company, Philadelphia, 1995.
  11. Schoub BD. The Quest for the HIV Vaccine. In: AIDS and HIV in Perspective. Cambridge University Press, 1999: 185-203.
  12. Duesberg PH. AIDS Acquired by Drug Consumption and other Non-contagious Risk Factors. Pharmac Ther 1992; 55:201-277.
  13. Duesberg PH, Rasnick D. The Drug-AIDS Hypothesis. Continuum (London) 1997; 4(5); S1-S24.
  14. Duesberg PH, Rasnick D. The AIDS Dilema. Drug Diseases Blamed on a Passenger Virus. Genetica 1998; 104: 85-132.
  15. Papadopulos-Eleopulos E. Reappraisal of AIDS - Is the Oxidation Induced by the Risk Factors the Primary Cause? Medical Hypothesis 1988; 25: 151-162.
  16. Papadopulos-Eleopulos E. Looking Back on the Oxidative Stress Theory of AIDS. Continuum (London) 1998/9; 5(5); 30-35.
  17. Giraldo RA. AIDS and Stressors II: A Proposal for the Pathogenesis of AIDS. Toxicology Letters Supplement 1/78. 1995: s34.
  18. Giraldo RA. AIDS and Stressors III: A Proposal for the Natural History of AIDS. Toxicology Letters Supplement 1/78. 1995: s35.
  19. Giraldo RA. AIDS and Stressors II: A Proposal for the Pathogenesis of AIDS. En: AIDS and Stressors. Medellín: Impresos Begón, 1997; 57-96.
  20. Giraldo RA. AIDS and Stressors III: A Proposal for the Natural History of AIDS. En: AIDS and Stressors. Medellín: Impresos Begón, 1997; 97-131.
  21. Caldwell JC, Caldwell P. The African AIDS Epidemic. In parts of sub-Saharan Africa, nearly 25 percent of the population is HIV-positive as a result of heterosexual transmission of the virus. Could lack of circumcision make men in this region particularly susceptible? Scientific American 1996; 274: 6268.
  22. Giraldo RA. AIDS and Stressors I: Worldwide Rise of Immunological Stressors. Toxicology Letters Supplement 1/78. 1995: s34.
  23. Giraldo RA. AIDS and Stressors I: Worldwide Rise of Immunological Stressors. En: AIDS and Stressors. Medellín: Impresos Begón, 1997; 23-56.
  24. Giraldo RA et al. Is It Rational To Treat or Prevent AIDS with Toxic Antiretrovital Drugs in Pregnant Women, Infants, Children, and Anybody Else? The Anser is Negative. Continuum (London) 1999; 5(6); 38-52.
  25. Papadopulos-Eleopulos E, Turner V, Papadimitriou JM. Is a Positive Western Blot Proof of HIV Infection? Bio/Technology 1993; 11: 696-707.
  26. Papadopulos-Eleopulos E, Turner V, Papadimitriou JM, Causer D. The Isolation of HIV: Has It Really Been Achieved? The Case Against. Continuum (London) September/October 1996; 4(3): S1-S24.
  27. Altman LK. Long Term Survivors May Hold Key Clues to Puzzle of AIDS. The New York Times: Science Times. p. c1 & C11, January 24, 1995.
  28. Levy JA. Overal Features of HIV Pathogenesis: Prognosis for Long-Term Survival. In: HIV and the Pathogenesis of AIDS. Secon Edition. Washington DC: ASM Press; 1998: 311-338.
  29. Kiecolt-Glaser JK, Glaser R. Psychological Influences on Immunity. Implications for AIDS. Amer J Psychol 1988; 43: 892-899.
  30. Stein M, Miller AH. Stress, the Immune System and Health and Illness. En: Goldberg L, Bretznitz S. Handbook of Stress: Theoretical and Clinical Aspects. New York: McMillan; 1993.
  31. Kemeny ME. Psychoimmunology of HIV Infection. In: Zegan LS, Coates TJ. Psychiatric Manifestations of HIV Disease. Psychiatric Clinics of North America 1994; 17: 55-68.
  32. Schedlowski M, Tewes U. Psychoneuroimmunology. An Interdisciplinary Introduction. New York: Kluwer Academic/Platinum Publishers; 1999; 582.
  33. Schneitherman N, et al. Psychoneuroimmunology and HIV/AIDS. In: Schedlowski M, Tewws U. Psychoneuroimmunology. New York: Kluwer Academic/Plenum Publishers 1999; 487-508.
  34. Irvin M, Friedman E. Does Psychological Depression Cause Immune Suppression in Humans? En: Schedlowski M, Tewes U. Psychoneuroimmunology. An Interdisciplinary Introducction. Chapter 17. New York: Kluwer Academic/Plenum Publishers; 1999; 327-340.
  35. Cherneckey CC, Berger BJ. Laboratory Tests and Diagnostic Procedures. 2nd Edition. Philadelphia: W.B. Sounders Co.; 1997; 1082.
  36. Fleisher TA. Evaluating Immunologic Function. En: Rich RR et al. Clinical Immunology. Principles and Practice. Section Eleven. St. Louis: Mosby, 1996; 2083-2087.
  37. Holsapple MP, Kaminski NE, Pruett SB. T Lymphocyte Subpopulations and Immunotoxicology of Drugs of Abuse. En: Kimber I, Selgrade MK. T Lymphocyte Subpopulations in Immunotoxicology. Chichester: John Wiley & Sons; 1998; 73-102.
  38. Cavanaugh BM. Tests for Lymphocyte Functions. Nurse’s Manual of Laboratory and Diagnostic Tests. 3rd Edition. Philadelphia: F.A. Davis Co.; 1999a; 82-94.
  39. McPherson RA, Nakamura RM. Laboratory Immunology I. Clinic in Laboratory Medicine 1992a; 12(1); 1-162.
  40. McPherson RA, Nakamura RM. Laboratory Immunology II. Clinic in Laboratory Medicine 1992b; 12(2); 163-392.
  41. Cavanaugh BM. Test for the Complement System. Nurse’s Manual of Laboratory and Diagnostic Tests. 3rd Edition. Philadelphia: F.A. Davis Co.; 1999b; 94-97.
  42. Cavanaugh BM. Autoantibody tests. Nurse’s Manual of Laboratory and Diagnostic Tests. 3rd Edition. Philadelphia: F.A. Davis Co.; 1999c; 98-102.
  43. Bogden JD et al. Micronutrients Status and Human Immunodeficiency Virus (HIV) Infection. Ann NY Acad Sci 1990; 587: 189-195.
  44. Hass E. Staying Healthy with Nutrition. Berkeley, CA: Celestial Arts; 1992.
  45. Steinman D. Diet for a Poisoned Planet. How to Choose Safe Food for You & Your Family. New York: Ballantine Books; 1992; 400.
  46. Labbe RF. Nutrition Support. Clinics in Laboratory Medicine 1993; 13(2); 323-530.
  47. Flaherty DK. Immunotoxicology and Risk Assessment. New York: Kluwer Academic/Plenum Publishers, 1999: 382.
  48. Simic MG. Urinary Biomarkers and the Rate of DNA Damage In Carcinogenesis and Anticarcinogenesis. Mutat Res 1992; 267: 277.
  49. Simic MG. DNA Markers of Oxidative Processes in Vivo: Relevance to Carcinogenesis and Anticarcinogenesis. Cancer Res (Suppl) 1994; 54: 1918s.
  50. Simic MG, Bergtold DS. Dietary Modulation of DNA damage in Human. Mutat Res 1991; 250: 17.
  51. Bashir S et al. Oxidative DNA Damage and Cellular Sensitivity to Oxidative Stress in Human Autoimmune Diseases. Ann Rheum Dis 1993; 52: 639.
  52. Favier A. The Place of Oxygen Free Radicals in HIV Infections. A collection of papers presented at a conference on "The place of oxygen free radicals in HIV infection", Les Deux Alpex, France, January 1993. Chem Biol Interac 1994; 91: 91-100.
  53. Vigue CA et al. Antioxidant Status and Indixes of Oxidative Stress During Consecutive Days Exercise. J Appl Physiol 1993; 75: 566.
  54. Tagesson C et al. Determination of Urinary 8-Hydroxydeoxyguanosine by Automated Coupled-Column High Performance Liquid Chromatography: A Powerful Technique for Assaying in Vivo Oxidative DNA Damage in Cancer Patients. Eur J Cancer 1995; 31A :934.
  55. Jovanovic S. Biomarkers of Oxidative Stress in Clinical Practice. Townsend Letter for Doctors & Patients 1998 (August/September); 72-76.
  56. Chaitow L. Body/Mind Purification Program. New York: Simon and Schuster/Gaia; 1990.
  57. Goldberg B. Detoxification Therapy. AIDS. En: Alternative Medicine. The Definitive Guide. Fife, Washington: Future Medicine Publishing Inc.; 1994; 156-166 and 494-509.
  58. Papadopulos-Eleopulos E, Turner V, Papadimitriou JM. Oxidative Stress, HIV and AIDS. Res Immunol 1992; 143: 145-148.
  59. Dworkin BM. Selenium Deficiency in HIV Infection and the Acquired Immune Deficiency Syndrome (AIDS). Chem Biol Interact 1994; 91: 181-186.
  60. Dworkin B, Rosenthal W, Wormser G, Weiss L. Selenium Deficiency in the Acquired Immuno-Deficiency Syndrome. J Parenteral Enteral Nutr 1986; 10: 405.
  61. Staal FJT et al. Intracellular Glutathione Levels In T-Cells Subsets Decrease in the Blood Plasma of HIV-1 Infected Patients. Biol Chem Hoppe Seyler 1989; 370: 101-108.
  62. Buhl R et al. Systemic Gluthation-Deficiency in Symptom-Free Seropositive Individuals. Lancet 1989; ii: 1294-1298.
  63. Turner VF. Reducing Agents and AIDS - Why Are We Waiting? Med J Austr 1990; 153: 502.
  64. Walter R, et al. Zinc Status in Human Immunodeficiency Virus Infection. Life Sci 1990; 47: 1579.
  65. Fuchs J et al. Oxidative Inbalance in HIV Infected Patients. Medical Hypothesis 1991; 36:60-64.
  66. Girelli A et al. Serum Selenium Concentration and Disease Progress in Patients with HIV-Infection. Clin Biochem 1991; 24: 211-214.
  67. Graham N et al. Relationship of Serum Cooper and Zinc Levels to HIV-1 Seropositivity and Progression to AIDS. J AIDS 1991; 4: 976.
  68. Halliwell B, Cross C. Reactive Oxygen Species, Antioxidants and Acquired Immunodeficiency Syndrome. Arch Intern Med 1991; 151: 29-31.
  69. Quey B, Malinverni R, Lautenburg BH. Glutathione Depletion in HIV-Infected Patients: Role of Cysteine Deficiency and Effect of Oral N-Acetyl-Cysteine. AIDS 1992; 5: 814.
  70. Salvain B, Mark AW. The Role of Oxidative Stress in Disease Progression in Individuals Infected by the Human Immunodeficiency Virus. J Leukocyte Biol 1992; 52: 111.
  71. Dorge W, Eck HL, Mihm S. HIV-Induced Cysteine Deficiency and T-Cell Dysfunction: A Rationale for Treatment with N-Acetylcysteine. Immunol Today 1992; 13: 211.
  72. Greenspan HC. The Role of Oxidative Oxygen Species, Antioxidants and Phytopharmaceuticals in Human Immunodeficiency Virus Activity. Med Hypothesis 1993; 40: 85.
  73. Greenspan HC, Arouma O. Oxidative Stress and Apoptosis in HIV Infection: A Role for Plant-Derived Metabolites with Synergistic Antioxidant Activity. Immunol Today 1994; 15: 209.
  74. Polyakov VM et al. Superoxide Anion (O2-) Production and Enzymatic Disbalance in Peripheral Blood Cells Isolated from HIV-Infected Children. Free Radic Biol Med 1994; 16: 15-21.
  75. Favier A et al. Antioxidant Status and Lipid Peroxidation in Patients Infected with HIV. Chem Biol Interac 1994; 91: 165-180.
  76. Piette J et al. Molecular Mechanisms of Virus Activation by Free Radicals. Collection of 5 articles presented at a conference on "The place of oxygen free radicals in HIV infections", Les Deux Alpes, France, January 1993. Chemico-Biological Interactions 1994; 91:79-132.
  77. Constants J et al. Faty Acids and Plasma Antioxidants in HIV-Positive Patients Correlation with Nutritional and Immunological Status. Clin Biochem 1995; 28: 421-426.
  78. Passi S. Progressive Increase of Oxidative Stress in Advancing Human Immunodeficiency. Continuum (London) 1998; 5(4); 20-26.
  79. Passi S et al. Study on Plasma Polyunsaturated Faty Acids and Vitamin E, and on Erythrocyte Glutathione Peroxidase in High Risk HIV Infection Categories and AIDS Patients. Clin Chem Enzym Comms 1993; 5: 169-177.
  80. Shallenberger F. Selective Compartmental Dominance: An Explanation for a Nonifectious, Multifactorial Etiology for Acquired Immune Deficiency Syndrome (AIDS), and a Rationale for Ozone Therapy and other Immune Modulating Therapies. Med Hypothesis 1998; 50: 67-80.
  81. Byrnes SC. Staying on Top of Oxidative Stress. Healthy and Natural Journal, Millenium Wellness Guide 1999b, en: sbyrnes@chaminade.edu, disponible en: http://www.powerhealth.net.
  82. Fabris N et al. AIDS, Zinc Deficiency and Thymic Hormone Failure. JAMA 1988; 259: 839.
  83. Brighthope I. The AIDS Fighters. The Role of Vitamin C and other Immunity-Building Nutrients. New Canaan, Connecticut: Keats Publishing; 1988; 184.
  84. Cathart R. Vitamin C in the Treatment of Acquired Immune Deficiency Syndrome (AIDS) Med Hypothesis 1984; 14: 423.
  85. Javier JJ et al. Antiooxidant Micronutrients and Immune Function in HIV-1 Infection. FASEB Proc 1990; 4A: 940-945.
  86. Block G et al. Vitamin C: A New Look. Ann Int Med 1991; 114: 909-910.
  87. Semba RD, Graham NMH, Caiaffa WT. Increased Mortality Associated with Vitamin A Deficiency During Human Immunodeficiency Virus Type 1 Infection. Arch Intern Med 1993; 153: 2149-2154.
  88. Bendich A. Role of Antioxidants in the Maintenance of Immune Function. En: Frei B. Natural Antioxidants in Human Health and Disease. Chapter IV, Immunity and Infection. San Diego: Academic Press; 1994; 447-467.
  89. Schrauzer GN, Sacher J. Selenium in the Maintenance and Therapy of HIV-Infected Patients. Chem Biol Inter 1994; 91: 199.
  90. Peterhans E. Oxidants and Antioxidants In Viral Diseases: Metabolic Regulation and Autotoxicity. In: Frei B. Natural Antioxidants in Human Health and Disease. San Diego: Academic Press; 1994: 489-514.
  91. Adam ES. Antioxidant Supplementation in HIV/AIDS. Nurse Pract 1995; 20: 8.
  92. Zhang Z, Inserra PF, Watson RR. Antioxidants and AIDS. En: Garewal HS. Antioxidants and Disease Prevention. Boca Raton: CRC Press; 1997; 45-66.
  93. Inserra PF, Ardestani SK, Ross Watsson R. Antioxidants and Immune Function. En: Garewal HS. Antioxidants and Disease Prevention. Boca Raton: CRC Press; Chapter 3; 1997; 19-30.
  94. Schultz V, Hansel R, Tyler VE. Agents that Increase Resistance to Diseases: Adaptogens; Immune Stimulants; Botanical Antioxidants. En: Rational Phytotherapy. A Physician Guide to Herbal Medicine. Springer; 1998; 269-273, 273-281, 282-286.
  95. Reid L. Oxidative Stress and Antioxidants. A Nutritional Perspective. Continuum (London) 1998; 5(3); 52-54.
  96. Beisel WR. Single Nutrients and Immunity. Am J Clin Nutr 1982; 35: 417-468.
  97. Beisel WR. The History of Nutritional Immunology. J Nutr Immunol 1991; 1: 62-78.
  98. Delafuente JC. Nutrients and Immune Responses. Rheum Dis Clin North Amer 1991; 17: 203-212.
  99. Watson RR. Nutrition and AIDS. Boca Raton: CRC Press, 1994.
  100. Hickson JF. Diet and Nutrition for Optimal Immune Function. In: Bahl SM, Hickson JF. Nutritional Care for HIV-Positive Persons: A Manual for Individuals and Their Caregivers. Boca Raton: CRC Press, 1995; 1-36.
  101. Passi S, De Luca C. Dietetic Advice for Immunodeficiency. Continuum (London) 1998/9; 5(5); 43-52.
  102. Mahan LK, Escott-Stump S. Medical Nutrition Therapy for Human Immunodeficiency Virus (HIV) Infection and Acquired Immunedeficiency Syndrome (AIDS). En: Krause’s Food, Nutrition, and Diet Therapy. Chapter 40. Philadelphia: W.B. Saunders Company; 2000; 889-911.
  103. Bahl SM & Hickinson JF. Nutritional Care for HIV-Positive Persons: A Manual for Individuals and Their Caregivers. Boca Raton: CRC Press, 1995.
  104. Woods JA. Immune Responses to Acute Exercise: Practical Applications for Exercise Prescription. En: Rippe JM. Lifestyle Medicine. Blackwell Science; 1999; 1125-1139.
  105. Atkins RC. Immune-Enhancing Herbs. Infection Fighters. En: Dr. Atkins’ Vita-Nutrient Solution. Nature’s Answer to Drugs. New York Fireside; 1999; 294-296 y 297-299.
  106. Byrnes SC. Conquering Candidiasis Naturally. Continuum (London) 1999a; 5(6); 34-37.
  107. Lee Y-K, Nomoto K, Salminen S, Gorbach SL. Handbook of Probiotics. New York: John Wiley & Sons, Inc.; 1999; 211.
  108. Pedersen BK. HIV Infection: Exercise and Immune Function. En: Rippe JM. Lifestyle Medicine. Blackwell Science; 1999; 1149-1158.
  109. Chaitow L, Martin S. A World Without AIDS. London: Thorsons Publishing Group; 1988.
  110. Garewal HS et al. A Preliminary Trial of Beta-Carotene in Subjects Infected with the Human Immunodeficiency Virus. J Nutr 1992; E22: 728.
  111. Harakeh S, Jariwalla RJ, Pauling L. Suppression of Human Immunodeficiency Virus Replication by Ascarbate in Chronically and Acutelly Infected Cells. Proc Natl Acad Sci U.S.A. 1990; 87: 7245.
  112. Anderson R et al. Vitamin C and Cellular Immune Functions. En: Bendich A y Chandra RD. Micronutrients and Immune Functions. New York Academy of Sciences; 1990; 34-38.
  113. Burns JJ et al. Third Conference on Vitamin C. Ann NY Acad Sci 1987; 498: 1-538.
  114. Malkovsky M et al. Acquired Immunological Torerance of Foreign Cells is Impaired by Recombinant Interleukin 2 or Vitamin A Acetate. Proc Nat Acad Sci (USA) 1985; 82: 536-538.
  115. Tyler VE. Herbs of Choice. The Therapeutic Use of Phytomedicinals. Chapter 12: Performance and Immunedeficiencies. New York: Pharmaceutical Products Press, 1994: 171-186.
  116. Robson EC, Schwartz MR. Vitamin B6 Deficiency and the Lymphoid System: Effects of Vitamin B6 Deficiency in utero on the Immunological Competence of the Offspring. Cell Immunol 1975; 16: 145-156.
  117. Da Prato RA, Rothschild J. The AIDS Virus is an Opportunistic Organism Inducing a State of Chronic Relative Cortisol Excess: Therapeutic Implications. Med Hypoth 1986; 21: 253-266.
  118. Flemenbaum A, Giraldo RA. Lithium for the Prevention, Treatment and Cure of AIDS. The Second World Congress on Drugs and Alcohol. Ramat Gam, Israel, November 13-17, 1988.
  119. Hand R. Alternative Therapies Used by Patients with AIDS. NEJM 1989; 320: 672-673.
  120. Abrams DL. Alternative Therapies. In: Repoza NP. HIV Infection and Disease. Monographs for Physicians and other health care workers. Chicago: AMA Press, 1989.
  121. Abrams DL. Alternative Therapies in HIV Infection. AIDS 1990; 4: 1179-1187.
  122. Abrams DL. Dealing with Alternative Therapies for HIV. In Sande MA & Volverding PA. The Medical Management of AIDS. Philadelphia: WB Saunders Company; 1995: 183-207.
  123. Abrams DL. Alternative Therapies. In: Dolin R et al. AIDS Therapy. New York: Churchill Livingstone, 1999: 219-226.
  124. Badgley L. Healing AIDS Naturally: Natural Therapies for the Immune System. Foster City, California: Human Energy Press; 1990; 410.
  125. Byrnes SC. Overcoming AIDS with Natural Medicine. Honolulu: Centaur Books; 1997; 219.
Roberto A. Giraldo



  Home     Mail     Links     Articles     Reports     Correspondence     An effective prevention for AIDS     Español